Update on Adjuvant Therapy in Late-Stage Resected Melanoma

H&O  Which patients with melanoma are candidates for adjuvant therapy? AT  Systemic adjuvant therapy that targets residual micrometastatic disease—which is the source of future melanoma relapse […]

Refining Dosing Strategies: Lessons From Singapore’s Health Care System

H&O  Could you provide an overview of the health care system in Singapore? BCG  The health care system in Singapore is centered on 2 basic tenets. […]

Evolving Standards of Care for Neoadjuvant and Adjuvant Therapy in Esophageal, Gastroesophageal Junction, and Gastric Cancer

Abstract: Multimodality therapy, which can include systemic therapy, radiation therapy, and surgery, is the preferred approach for most localized, clinical T2 to T4, and/or node-positive esophageal, […]

Umbralisib and Ublituximab: An Upcoming Regimen for Chronic Lymphocytic Leukemia

H&O  What types of drugs are umbralisib and ublituximab? JG  Umbralisib (Ukoniq, TG Therapeutics) is a phosphoinositide 3 (PI3) kinase delta inhibitor. Umbralisib is approved for […]

The Emergence of Targetable Pathways in Colorectal Cancer

Abstract: Colorectal cancer continues to be one of the leading causes of cancer-related morbidity and mortality globally. Despite an overall decreasing incidence of the disease, early-onset […]

Combination Therapy With Radium-223 and Enzalutamide in Castration-Resistant Prostate Cancer

H&O  What question was your recent study in The Oncologist designed to answer? BLM  We recently published the final results of our phase 2 study, which […]

The Use of Immunotherapy in Triple-Negative Breast Cancer

H&O  Which patients with triple-negative breast cancer (TNBC) are eligible for immunotherapy?  PS  We generally use immunotherapy in TNBC for 2 indications. One indication is the […]

Letter From the Editor: Nursing Help Wanted

Shortfalls in staffing are hurting many sectors of our economy, but health care seems to be taking a particularly hard hit. Nurses have been in short […]

Back to Archive